<!DOCTYPE html><html><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1"/><title>Neuraxpharm | Permira</title><meta name="robots" content="index,follow"/><meta name="googlebot" content="index,follow"/><meta name="description" content="Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis."/><meta property="og:title" content="Neuraxpharm | Permira"/><meta property="og:description" content="Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis."/><link rel="canonical" href="https://www.permira.com/portfolio/our-portfolio/neuraxpharm/"/><meta name="google-site-verification" content="Nd8hWdAqqvXuwbAn3xvEO9UOvXsnP-oauHB5gk2mro8"/><link rel="shortcut icon" href="https://media.permira.com/media/bqjph5wp/permira_favicon-01.png"/><meta name="title" content="Neuraxpharm | Permira"/><meta name="keywords" content=""/><meta name="thumbnail" content="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg"/><meta property="og:url" content="https://www.permira.com/portfolio/our-portfolio/neuraxpharm/"/><meta property="og:title" content="Neuraxpharm | Permira"/><meta property="og:description" content="Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis."/><meta property="og:image" content="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg"/><script type="application/ld+json">{"@context" : "http://schema.org",
 "@type" : "Organization",  
  "name" : "Permira",
  "url" : "https://www.permira.com", 
  "logo": "https://media.permira.com/media/4d3gjitw/og-image_permira_logo.png" 
}</script><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><link rel="preload" as="image" imagesrcset="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=3840&amp;q=75 3840w" imagesizes="100vw"/><meta name="next-head-count" content="31"/><link rel="preload" href="/_next/static/css/5f8a971221161002.css" as="style"/><link rel="stylesheet" href="/_next/static/css/5f8a971221161002.css" data-n-g=""/><link rel="preload" href="/_next/static/css/aedeadd8a2241807.css" as="style"/><link rel="stylesheet" href="/_next/static/css/aedeadd8a2241807.css" data-n-p=""/><link rel="preload" href="/_next/static/css/f851365138532338.css" as="style"/><link rel="stylesheet" href="/_next/static/css/f851365138532338.css" data-n-p=""/><link rel="preload" href="/_next/static/css/bfd109b78a087a77.css" as="style"/><link rel="stylesheet" href="/_next/static/css/bfd109b78a087a77.css" data-n-p=""/><link rel="preload" href="/_next/static/css/132ec4df2922b4d2.css" as="style"/><link rel="stylesheet" href="/_next/static/css/132ec4df2922b4d2.css" data-n-p=""/><link rel="preload" href="/_next/static/css/662c40b3cb9d3768.css" as="style"/><link rel="stylesheet" href="/_next/static/css/662c40b3cb9d3768.css" data-n-p=""/><link rel="preload" href="/_next/static/css/9c461d19ccd3c372.css" as="style"/><link rel="stylesheet" href="/_next/static/css/9c461d19ccd3c372.css" data-n-p=""/><link rel="preload" href="/_next/static/css/a9b690d79724b688.css" as="style"/><link rel="stylesheet" href="/_next/static/css/a9b690d79724b688.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-6aa36a62c7d81a68.js" defer=""></script><script src="/_next/static/chunks/framework-284b78a8b4062545.js" defer=""></script><script src="/_next/static/chunks/main-35b987eb63771833.js" defer=""></script><script src="/_next/static/chunks/pages/_app-8518e3d5c81471dd.js" defer=""></script><script src="/_next/static/chunks/d6e1aeb5-c1f9bb9d70481982.js" defer=""></script><script src="/_next/static/chunks/ea88be26-b6d4fa854ede18f0.js" defer=""></script><script src="/_next/static/chunks/7d0bf13e-9a4846d40356fad5.js" defer=""></script><script src="/_next/static/chunks/383-4c3dda81b72a7e08.js" defer=""></script><script src="/_next/static/chunks/5675-308067e206b54399.js" defer=""></script><script src="/_next/static/chunks/6066-38852223f7d3e680.js" defer=""></script><script src="/_next/static/chunks/2050-cd4468df70c31bf9.js" defer=""></script><script src="/_next/static/chunks/9260-63a66a557d163d6d.js" defer=""></script><script src="/_next/static/chunks/1950-31c114f04cb6fc77.js" defer=""></script><script src="/_next/static/chunks/1476-1b657bf27c238dc6.js" defer=""></script><script src="/_next/static/chunks/7876-8b64d96501906d89.js" defer=""></script><script src="/_next/static/chunks/8089-e9b04c6d077a1c12.js" defer=""></script><script src="/_next/static/chunks/2346-f39ce338f3208872.js" defer=""></script><script src="/_next/static/chunks/7747-21831d2ba89c99dc.js" defer=""></script><script src="/_next/static/chunks/8226-5dc49afa3b15615e.js" defer=""></script><script src="/_next/static/chunks/9811-6c6f5f5edfed1332.js" defer=""></script><script src="/_next/static/chunks/7078-501a2fe6be91f4ef.js" defer=""></script><script src="/_next/static/chunks/4745-1b9841ac901e1456.js" defer=""></script><script src="/_next/static/chunks/7312-e6cd27da178e7a6f.js" defer=""></script><script src="/_next/static/chunks/pages/portfolio/our-portfolio/%5B...pagepath%5D-443f76dfc5b36d52.js" defer=""></script><script src="/_next/static/6ZnPWxhlX7ngAr_ybXEs9/_buildManifest.js" defer=""></script><script src="/_next/static/6ZnPWxhlX7ngAr_ybXEs9/_ssgManifest.js" defer=""></script></head><body><div id="__next" data-reactroot=""><header class="Header_el__SSx8u   Header_noSplash__IQEm_ "><div class="Header_container__FGbDi container"><div><a class="Header_logo__SAQTw " href="/"><img class="Header_logoWhite__KCNYp" src="https://media.permira.com/media/opchnm2m/logo-light.png" alt="permira logo white 2"/><img class="Header_logoBlue__gXz25" src="https://media.permira.com/media/teup2dbc/logo-dark.png" alt="permira logo blue 2"/></a></div><div class="Header_mobileRight__rznjN"><a href="#" class="Header_searchBtnMobile__fivRA" aria-label="search"><span class="icon-search" aria-hidden="true"></span></a><button type="button" class="Header_mobileMenuBtn__8jPQs "><span></span><span></span><span></span><span class="sr-only">menu</span></button></div><div class="Header_right__YhatV  "><div class="Header_mobileMenu__3k2cW"><div class="Header_secondNav__dpVYF"><div class="Header_secondNavItem__2gHMw"><a target="" href="/contact-us">Contact Us</a></div><div class="Header_secondNavItem__2gHMw"><a disabled="" tabindex="-1" target="" class="Header_hasChild__sgADx">International Sites<span class="Header_arrowDown__y3vmq "></span></a><div class="Header_secondNavPop__dHRpX "><a target="_blank" href="https://www.permira.cn/" rel="noopener noreferrer">Permira China</a></div></div><div class="Header_secondNavItem__2gHMw Header_search__y_4oc"><a href="#" aria-label="search"><span class="icon-search" aria-hidden="true"></span></a></div><div class="Header_social__2r_Ge"><a aria-label="wechat" href="https://media.permira.com/media/3ivl4au1/wechat-qr.jpg" target="_blank" rel="noopener noreferrer"><span class="icon-wechat" aria-hidden="true"></span></a><a aria-label="vimeo" href="https://vimeo.com/permiraadvisers#" target="_blank" rel="noopener noreferrer"><span class="icon-vimeo" aria-hidden="true"></span></a><a aria-label="youtube" href="https://www.youtube.com/user/PermiraTV#" target="_blank" rel="noopener noreferrer"><span class="icon-youtube" aria-hidden="true"></span></a><a aria-label="twitter" href="https://twitter.com/PermiraNews#" target="_blank" rel="noopener noreferrer"><span class="icon-twitter" aria-hidden="true"></span></a><a aria-label="linkedin" href="https://www.linkedin.com/company/permira#" target="_blank" rel="noopener noreferrer"><span class="icon-linkedin" aria-hidden="true"></span></a></div></div><div class="Header_mainNav__08eOw"><div class="Header_mainNavItem__oQsLk  " data-id="0"><a href="/people">People<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="0"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>People</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" " href="/people/meet-our-people">Meet Our People<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/people/culture-and-values">Culture and Values<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/people/life-at-permira">Life at Permira<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/d4jjudku/ea-option-1.jpg" alt=""/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">People</div><div class="Header_description__VVh7x">A global team bound by a distinct culture. Our collaborative and entrepreneurial culture unites a diverse team of 480+ individuals across 15 offices around the world.  </div><div class="Header_cta__b1sck"><a href="/people/meet-our-people">MEET OUR PEOPLE<span class="icon-arrow-right" aria-hidden="true"></span></a></div></div></div></div></div></div></div><div class="Header_mainNavItem__oQsLk  " data-id="1"><a href="/investing">Investing<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="1"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>Investing</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" " href="/investing/buyout">Buyout<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/investing/growth-equity">Growth Equity<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/investing/credit">Credit<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/bkhlrm3m/bosco-shots-slr66yjpsoi-unsplash-2.jpg" alt=""/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">Investing</div><div class="Header_description__VVh7x">We apply a thematic approach across two core asset classes - Private Equity and Credit - with a focus on growth in our four key sectors of expertise: Technology, Consumer, Healthcare and Services. </div><div class="Header_cta__b1sck"><a href="/investing">LEARN MORE<span class="icon-arrow-right" aria-hidden="true"></span></a></div></div></div></div></div></div></div><div class="Header_mainNavItem__oQsLk Header_active__SBcCE " data-id="2"><a href="/portfolio">Portfolio<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="2"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>Portfolio</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" Header_orange__JoZOj" href="/portfolio/our-portfolio">Our Portfolio<span class="icon-arrow-right" aria-hidden="true"></span></a><a class="Header_leftPadding__YpQHW " href="/portfolio/technology">Technology<span class="icon-arrow-right" aria-hidden="true"></span></a><a class="Header_leftPadding__YpQHW " href="/portfolio/consumer">   Consumer<span class="icon-arrow-right" aria-hidden="true"></span></a><a class="Header_leftPadding__YpQHW " href="/portfolio/healthcare">   Healthcare<span class="icon-arrow-right" aria-hidden="true"></span></a><a class="Header_leftPadding__YpQHW " href="/portfolio/services">   Services<span class="icon-arrow-right" aria-hidden="true"></span></a><a class="Header_leftPadding__YpQHW " href="/portfolio/value-creation-team">Value Creation Team<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/x3ibcksn/shutterstock_691685071-1.jpg" alt=""/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">Portfolio</div><div class="Header_description__VVh7x">We're supporting management teams and entrepreneurs, helping them to drive growth at scale and long-term value creation across four core sectors.  </div><div class="Header_cta__b1sck"><a href="/portfolio">READ MORE<span class="icon-arrow-right" aria-hidden="true"></span></a></div></div></div></div></div></div></div><div class="Header_mainNavItem__oQsLk  " data-id="3"><a href="/responsibility">Responsibility<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="3"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>Responsibility</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" " href="/responsibility/investing-responsibly">Investing Responsibly <span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/responsibility/permira-foundation">The Permira Foundation<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/nb5i4akv/joel-filipe-asl4k-u3i_s-unsplash.jpeg" alt=""/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">Responsibility</div><div class="Header_description__VVh7x">A values-based approach and a deep commitment to ESG guide our thinking. </div><div class="Header_cta__b1sck"><a href="/responsibility">LEARN ABOUT OUR APPROACH<span class="icon-arrow-right" aria-hidden="true"></span></a></div></div></div></div></div></div></div><div class="Header_mainNavItem__oQsLk  " data-id="4"><a href="/news-and-insights">News &amp; Insights<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="4"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>News &amp; Insights</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" " href="/news-and-insights/insights">Insights<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/news-and-insights/news">News<span class="icon-arrow-right" aria-hidden="true"></span></a><a class=" " href="/news-and-insights/in-the-news">In the News<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/mgrhse35/rectangle-20387.jpg" alt="Management meeting - Private equity services - Permira"/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">News &amp; Insights</div><div class="Header_description__VVh7x">Explore articles, press releases, views and opinions from Permira, across our portfolio and the industry.</div></div></div></div></div></div></div><div class="Header_mainNavItem__oQsLk  " data-id="5"><a href="/about">About<span class="icon-arrow-down"></span></a><button class="Header_expandBtn__YOsEd" data-id="5"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">expand</span></button><div class="Header_megaWrap__fGqkW "><div class="Header_mobileHeader__vy11F"><button type="button" class="Header_backBtn__Ik1rb"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">back</span></button><h5>About</h5><button class="Header_closeBtn__X2te1"><span class="icon-close" aria-hidden="true"></span><span class="sr-only">close</span></button></div><div class="Header_container__FGbDi container"><div class="Header_subnavs__sMOv4"><a class=" " href="/about/permira-today">Permira Today<span class="icon-arrow-right" aria-hidden="true"></span></a></div><div class="Header_info__T8XRs"><div class="Header_adjoiningContent__MPM0_ Header_default__HDH_p"><div class="Header_image__CAAHc"><img src="https://media.permira.com/media/hikfrq4b/shutterstock_1880519176.jpg" alt=""/></div><div class="Header_content___w3_k"><div class="Header_tag__4kfao">About</div><div class="Header_description__VVh7x">Driving long-term value creation. Accelerating sustainable growth at scale. Partnering to unlock potential.</div><div class="Header_cta__b1sck"><a href="/about/permira-today">READ MORE<span class="icon-arrow-right" aria-hidden="true"></span></a></div></div></div></div></div></div></div></div></div></div></div><div class="Header_searchBox__9SkOm "><div class="Header_beforeOverlay__nnpPb"></div><div class="Header_container__FGbDi container"><div class="Header_wrapper__7eLx6"><form action="/search"><label for="search-keyword" class="sr-only">Search</label><input type="text" id="search-keyword" class="Header_searchInput__ToGib" placeholder="Search" name="keyword" required=""/><button class="Header_searchSubmit__ei5hD" type="submit"><span class="icon-arrow-right" aria-hidden="true"></span><span class="sr-only">submit</span></button><button class="Header_searchCancel__e7t8w" aria-label="Close Search" title="Close Search"><span class="icon-close" aria-hidden="true"></span></button></form></div></div><div class="Header_afterOverlay__RRHH0"></div></div></header><main class="main-content no-splash" id="main-content"><div class="Breadcrumb_el___ycJc breadcrumb Breadcrumb_inner__kV5dU"><div class="Breadcrumb_container__rWHLB container"><a href="/">Home</a><span> / </span><a href="/portfolio">Portfolio</a><span> / </span><a href="/portfolio/our-portfolio">Our Portfolio</a><span> / </span><a disabled="" tabindex="-1">Neuraxpharm</a></div></div><div class="CaseStudyScrollHijack_el__V2ba6"><div class="CaseStudyScrollHijack_innerHeader__PVNRe"><div class="CaseStudyScrollHijack_content__tzpo8"><div class="CaseStudyScrollHijack_container__awy3P container"><div class="CaseStudyScrollHijack_contentWrapper__msZMb"><div class="CaseStudyScrollHijack_companyGroups__NQOdm"><div class="CaseStudyScrollHijack_icon__r6tQn"><img src="https://media.permira.com/media/lvwnaywl/neuraxpharm_logo.png" alt=""/></div><div class="CaseStudyScrollHijack_companyName__nEJor">Neuraxpharm</div></div><div class="CaseStudyScrollHijack_companyDescription__fwvXg"><I> “We are very excited to join forces with Neuraxpharm. The team has built one of the most relevant European players in the CNS field.” </I><br /><b> Dr. Jörg Rockenhäuser - Partner and Head of DACH at Permira </b><br /><br />Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.<br /><br />With one of the broadest and most diversified product portfolios of over 130 CNS molecules, a strong medical reputation and deep CNS experience, the company holds leading positions in its core markets, Germany and Spain, and across Europe in many of its CNS molecules. <br /><br />The Company also enjoys a strong track record of successfully in-licensing innovative CNS drugs and has emerged as a go-to commercialization & distribution partner in Europe. <br /></div><div class="CaseStudyScrollHijack_companyDetails__WFKiV"><div class="CaseStudyScrollHijack_headingText__GOIpx">DETAILS</div><div class="CaseStudyScrollHijack_companyDetailsRow__mHKu1"><img src="/images/casestudy/ico.sector.svg" alt=""/><p>Sector</p><p>Healthcare</p></div><div class="CaseStudyScrollHijack_companyDetailsRow__mHKu1"><img src="/images/casestudy/ico.countryregion.svg" alt=""/><p>Country or Region</p><p>Germany<!-- -->, <!-- -->Spain</p></div><div class="CaseStudyScrollHijack_companyDetailsRow__mHKu1"><img src="/images/casestudy/ico.status.svg" alt=""/><p>Status</p><p>Current</p></div><div class="CaseStudyScrollHijack_companyDetailsRow__mHKu1"><img src="/images/casestudy/ico.website.svg" alt=""/><p>Website</p><p><a href="http://www.neuraxpharm.com" target="_blank" rel="noopener noreferrer">www.neuraxpharm.com</a></p></div></div></div></div></div><div class="CaseStudyScrollHijack_scrollGroup__H_bp_"><div class="CaseStudyScrollHijack_image__z6a2G" style="background-image:url(https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg)"></div><div class="CaseStudyScrollHijack_fourColsInfo__lNFx_"><div class="CaseStudyScrollHijack_container__awy3P container"><div class="CaseStudyScrollHijack_contentStats__IvwE9"><div class="CaseStudyScrollHijack_stats__9ib02"><div class="CaseStudyScrollHijack_statsInfo__f_0cp"><div class="h1 CaseStudyScrollHijack_statsTitle__6RvPS">2020</div><div class="CaseStudyScrollHijack_statsDesc__qt5bR"><p>Investment year</p></div></div><div class="CaseStudyScrollHijack_statsInfo__f_0cp"><div class="h1 CaseStudyScrollHijack_statsTitle__6RvPS">&gt;130</div><div class="CaseStudyScrollHijack_statsDesc__qt5bR"><p>CNS Molecules</p></div></div><div class="CaseStudyScrollHijack_statsInfo__f_0cp"><div class="h1 CaseStudyScrollHijack_statsTitle__6RvPS">#1</div><div class="CaseStudyScrollHijack_statsDesc__qt5bR"><p>CNS specialist in Europe</p></div></div></div></div></div></div></div></div></div><div class="PeopleList_el__iAGNA people-list PeopleList_diffLayout__dUY08 PeopleList_noBorder__UQLWz"><div class="CarouselStandard_container__GrwQx PeopleList_carouselOverrides__nbBDN container"><div class="CarouselStandard_slickArrows__tJ76w"><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_prevBtn___7Wnt false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">previous</div></button><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_nextBtn__5rQyx false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">next</div></button></div><div class="CarouselStandard_title__XtqoJ"><h2>Related Team</h2></div><div class="CarouselStandard_wrapper__ijCOj"><div class="slick-slider slick-initialized" dir="ltr"><div class="slick-list"><div class="slick-track" style="width:1200%;left:0%"><div data-index="0" class="slick-slide slick-active slick-current" tabindex="-1" aria-hidden="false" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="David Brueckmann" href="/people/meet-our-people/david-brueckmann"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fzv1ltrzs%2Fdavid-brueckmann.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">David Brueckmann</div></a></div></div></div><div data-index="1" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Javier Echávarri Fernández" href="/people/meet-our-people/javier-echavarri-fernandez"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fulrlmjd2%2Fjavier-echavarri.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Javier Echávarri Fernández</div></a></div></div></div><div data-index="2" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Ulrich Gasse" href="/people/meet-our-people/ulrich-gasse"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F51rdgy2z%2Fulrich-gasse.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Ulrich Gasse</div></a></div></div></div><div data-index="3" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Florian Kreuzer" href="/people/meet-our-people/florian-kreuzer"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fr4xna4hu%2Fflorian-kreuzer.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Florian Kreuzer</div></a></div></div></div><div data-index="4" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Pedro López" href="/people/meet-our-people/pedro-lopez"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Ftgjh4sfj%2Fpedro-lopez.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Pedro López</div></a></div></div></div><div data-index="5" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Timon Müller-Gastell" href="/people/meet-our-people/timon-muller-gastell"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fybpojvgf%2Ftimon-muller-gastell_web.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Timon Müller-Gastell</div></a></div></div></div><div data-index="6" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Silvia Oteri" href="/people/meet-our-people/silvia-oteri"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fpxclxrvd%2Fsilvia-oteri.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Silvia Oteri</div></a></div></div></div><div data-index="7" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="José Maria Palicio" href="/people/meet-our-people/jose-maria-palicio"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fxe3cb4oh%2Fjosemaria-palicio.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">José Maria Palicio</div></a></div></div></div><div data-index="8" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Jörg Rockenhäuser" href="/people/meet-our-people/jorg-rockenhauser"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3tcb0qxn%2Fjorg-rockenhauser.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Jörg Rockenhäuser</div></a></div></div></div><div data-index="9" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Simon Roggentin" href="/people/meet-our-people/simon-roggentin"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Frrlncns5%2Fsimon-roggentin-permira.png&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Simon Roggentin</div></a></div></div></div><div data-index="10" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Michael Reichard" href="/people/meet-our-people/michael-reichard"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F1jyl5m0m%2Fmichael-reichard_web.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Michael Reichard</div></a></div></div></div><div data-index="11" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:8.333333333333334%"><div><div class="PeopleList_outerImageWrap__VlBk4" tabindex="-1" style="width:100%;display:inline-block"><a class="PeopleList_peopleImg__6EoKg" aria-label="Felix Wallner" href="/people/meet-our-people/felix-wallner"><div class="PeopleList_imageWrap__twRpZ"><div class="PeopleList_image__oeBBb"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="Team Member" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2F3kkhicpg%2Ffelix-wallner_web.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/></span></div></div><div class="PeopleList_peopleName__urPkW">Felix Wallner</div></a></div></div></div></div></div></div></div></div></div><div class="RelatedNews_el__X2Q2_ related-news"><div class="CarouselStandard_container__GrwQx RelatedNews_carouselOverrides__aUbz9 container"><div class="CarouselStandard_slickArrows__tJ76w"><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_prevBtn___7Wnt false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">previous</div></button><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_nextBtn__5rQyx false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">next</div></button></div><div class="CarouselStandard_title__XtqoJ"><h2>Related News &amp; Insights</h2></div><div class="CarouselStandard_secondaryText__sVWiq"></div><div class="CarouselStandard_wrapper__ijCOj"><div class="slick-slider slick-initialized" dir="ltr"><div class="slick-list"><div class="slick-track" style="width:900%;left:0%"><div data-index="0" class="slick-slide slick-active slick-current" tabindex="-1" aria-hidden="false" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/lxudi4pn/neuraxpharm-featured-image.jpg" alt=""/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">1 Aug 2023</div></div><div class="NewsCard_title__pmQCI"><h4>TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy) </h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/tg-therapeutics-and-neuraxpharm-announce-ex-us-commercialization-agreement-for-briumvi-ublituximab-xiiy">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="1" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg" alt=""/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">24 Jan 2023</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="2" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg" alt=""/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">13 Dec 2022</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm expands into the Netherlands</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-expands-into-the-netherlands">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="3" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg" alt=""/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">25 Oct 2022</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-steps-into-the-digital-health-market-with-a-wearable-device-developed-by-mjn-neuro-that-provides-an-early-warning-of-epileptic-seizures">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="4" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg" alt=""/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">12 Jul 2022</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="5" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg" alt="Neuraxpharm logo on a building"/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">8 Mar 2022</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm expands its business in Southeast Europe</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-expands-its-business-in-southeast-europe">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="6" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg" alt="Neuraxpharm logo on a building"/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">1 Jun 2021</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm appoints commercial expert Dr. Maximilian von Wülfing as Chief Operating Officer</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-appoints-commercial-expert-dr-maximilian-von-wulfing-as-chief-operating-officer">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="7" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg" alt="Neuraxpharm logo on a building"/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">14 Dec 2020</div></div><div class="NewsCard_title__pmQCI"><h4>Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div><div data-index="8" class="slick-slide" tabindex="-1" aria-hidden="true" style="outline:none;width:11.11111111111111%"><div><div class="NewsCard_el__kf0Pn "><div class="NewsCard_image__TYdIW"><img src="https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg" alt="Neuraxpharm logo on a building"/></div><div class="NewsCard_content__vrhR7"><div class="NewsCard_tag__9TewL"><div class="NewsCard_tagBox__PXynf">News</div><div class="NewsCard_date__IdUmR">22 Sep 2020</div></div><div class="NewsCard_title__pmQCI"><h4>Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm</h4></div><div class="NewsCard_cta__2Zph3"><a class="arrow-link" href="/news-and-insights/news/permira-funds-to-acquire-leading-european-cns-specialty-pharmaceutical-company-neuraxpharm">READ MORE<!-- --> <span class="icon-arrow-right"></span></a></div><div class="NewsCard_tags__0N70N"></div></div></div></div></div></div></div></div></div></div></div><div class="RelatedNews_el__X2Q2_ related-news"><div class="CarouselStandard_container__GrwQx RelatedNews_carouselOverrides__aUbz9 container"><div class="CarouselStandard_slickArrows__tJ76w"><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_prevBtn___7Wnt false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">previous</div></button><button class="CarouselStandard_slickArrow__t_0Wm CarouselStandard_nextBtn__5rQyx false"><div class="icon-arrow-right" aria-hidden="true"></div><div class="sr-only">next</div></button></div><div class="CarouselStandard_title__XtqoJ"><h2>Reporting</h2></div><div class="CarouselStandard_wrapper__ijCOj"><div class="slick-slider slick-initialized"><div class="slick-list"><div class="slick-track" style="width:100%;left:0%"><div data-index="0" class="slick-slide slick-active slick-current" tabindex="-1" aria-hidden="false" style="outline:none;width:100%"><div><div class="RelatedNews_reportCard__h_S_e"><div class="ReportCard_el__M526m"><div class="ReportCard_content__m6_l2 "><div class="ReportCard_wrapper__1EV7i"><div class="ReportCard_image__DVFxE"><div class="ReportCard_imageWrap__JuWny"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" sizes="100vw" srcSet="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=640&amp;q=75 640w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=750&amp;q=75 750w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=828&amp;q=75 828w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=1080&amp;q=75 1080w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=1200&amp;q=75 1200w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=1920&amp;q=75 1920w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=2048&amp;q=75 2048w, /_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=3840&amp;q=75 3840w" src="/_next/image?url=https%3A%2F%2Fmedia.permira.com%2Fmedia%2Fnnzc3bg2%2Fgeneric-news-image.jpg&amp;w=3840&amp;q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div></div><div class="ReportCard_wrapper__1EV7i ReportCard_right__wd1uV"><div class="ReportCard_header__L8l2z"><div class="ReportCard_type__lVdn9">Healthcare</div><div class="ReportCard_date__JYLi_">12 Oct 2023</div></div><div class="ReportCard_title__AbT_r"><h4 class="ReportCard_description__QpfHR">Neuraxpharm ESG Report 2022</h4></div><div class="ReportCard_button__J4a_Q"><a class="arrow-link" href="https://media.permira.com/media/03oflejj/neuraxpharm-esg-report-2022.pdf" target="_blank" rel="noopener noreferrer" download="">Download<!-- --> <span class="icon-download"></span></a></div></div></div></div></div></div></div></div></div></div></div></div></div></main><div class="BackToTop_el__NI_ES "><button type="button" class="BackToTop_inner__cbZCv "><span class="icon-arrow-up" aria-hidden="true"></span><span class="BackToTop_secretArrow__z4zTk icon-arrow-up" aria-hidden="true"></span><span class="sr-only">back to top</span></button></div><footer class="Footer_el__UjN6_" id="footer"><div class="Footer_top__qEiyn"><div class="Footer_container__Vebor container"><div class="Footer_sitemap__MmTOv"><div class="Footer_sitemapCol__R4tK4"><div class="Footer_sitemapBlock__m4f_6 " style="--max-h:75px"><h5><a href="/people">People</a></h5><a class="Footer_sitemapLink__sw8s4" href="/people/meet-our-people">Meet Our People</a><a class="Footer_sitemapLink__sw8s4" href="/people/culture-and-values">Culture and Values</a><a class="Footer_sitemapLink__sw8s4" href="/people/life-at-permira">Life at Permira</a></div><div class="Footer_sitemapBlock__m4f_6 Footer_last__dYRSp" style="--max-h:50px"><h5><a href="/responsibility">Responsibility</a></h5><a class="Footer_sitemapLink__sw8s4" href="/responsibility/investing-responsibly">Investing Responsibly</a><a class="Footer_sitemapLink__sw8s4" href="/responsibility/permira-foundation">The Permira Foundation</a></div></div><div class="Footer_sitemapCol__R4tK4"><div class="Footer_sitemapBlock__m4f_6 " style="--max-h:75px"><h5><a href="/investing">Investing</a></h5><a class="Footer_sitemapLink__sw8s4" href="/investing/buyout">Buyout</a><a class="Footer_sitemapLink__sw8s4" href="/investing/growth-equity">Growth Equity</a><a class="Footer_sitemapLink__sw8s4" href="/investing/credit">Credit</a></div><div class="Footer_sitemapBlock__m4f_6 Footer_last__dYRSp" style="--max-h:50px"><h5><a href="/about">Insights &amp; News</a></h5><a class="Footer_sitemapLink__sw8s4" href="/news-and-insights/insights">Insights</a><a class="Footer_sitemapLink__sw8s4" href="/news-and-insights/news">News</a></div></div><div class="Footer_sitemapCol__R4tK4"><div class="Footer_sitemapBlock__m4f_6 " style="--max-h:125px"><h5><a href="/portfolio">Portfolio</a></h5><a class="Footer_sitemapLink__sw8s4" href="/portfolio/our-portfolio">Our Portfolio</a><a class="Footer_sitemapLink__sw8s4" href="/portfolio/technology">Technology</a><a class="Footer_sitemapLink__sw8s4" href="/portfolio/consumer">Consumer</a><a class="Footer_sitemapLink__sw8s4" href="/portfolio/healthcare">Healthcare</a><a class="Footer_sitemapLink__sw8s4" href="/portfolio/services">Services</a></div><div class="Footer_sitemapBlock__m4f_6 Footer_last__dYRSp" style="--max-h:25px"><h5><a href="/about">About</a></h5><a class="Footer_sitemapLink__sw8s4" href="/about/permira-today">Permira Today</a></div></div><div class="Footer_sitemapCol__R4tK4"><div class="Footer_sitemapBlock__m4f_6 " style="--max-h:225px"><h5><a disabled="" tabindex="-1">Others</a></h5><a class="Footer_sitemapLink__sw8s4" href="/governance">Governance</a><a class="Footer_sitemapLink__sw8s4" href="/legal">Legal</a><a class="Footer_sitemapLink__sw8s4" href="/privacy-policy">Privacy Policy</a><a class="Footer_sitemapLink__sw8s4" href="/cookie-notice">Cookie Notice</a><a class="Footer_sitemapLink__sw8s4" href="/modern-slavery-act">MSA</a><a class="Footer_sitemapLink__sw8s4" href="/pgl">PGL</a><a class="Footer_sitemapLink__sw8s4" href="/pillar-3-disclosures">Pillar 3 Disclosures</a><a class="Footer_sitemapLink__sw8s4" href="/crd-iv-disclosure">CRD IV Disclosure</a><a class="Footer_sitemapLink__sw8s4" href="/mifidpru-8-disclosures">MIFIDPRU 8 Disclosures</a></div></div></div><div class="Footer_logo__EaWBg"><a href="/"><img src="https://media.permira.com/media/duglf2pa/logowhite.png" alt="permira logo white"/></a></div></div></div><div class="Footer_bottom__C0noJ"><div class="Footer_container__Vebor container"><div class="Footer_flexrow__bNs6P Footer_last__dYRSp"><div class="Footer_social__2_oMI"><a aria-label="wechat" href="https://media.permira.com/media/3ivl4au1/wechat-qr.jpg" target="_blank" rel="noopener noreferrer"><span class="icon-wechat" aria-hidden="true"></span></a><a aria-label="vimeo" href="https://vimeo.com/permiraadvisers#" target="_blank" rel="noopener noreferrer"><span class="icon-vimeo" aria-hidden="true"></span></a><a aria-label="youtube" href="https://www.youtube.com/user/PermiraTV#" target="_blank" rel="noopener noreferrer"><span class="icon-youtube" aria-hidden="true"></span></a><a aria-label="twitter" href="https://twitter.com/PermiraNews#" target="_blank" rel="noopener noreferrer"><span class="icon-twitter" aria-hidden="true"></span></a><a aria-label="linkedin" href="https://www.linkedin.com/company/permira#" target="_blank" rel="noopener noreferrer"><span class="icon-linkedin" aria-hidden="true"></span></a></div><div>© 2024 Permira I.P Limited</div></div></div></div></footer></div><script id="__NEXT_DATA__" type="application/json">{"props":{"initialProps":{"pageProps":{"Global":{"id":"1192c9f6-9299-4d0b-83c4-39d01d01c618","ga_id":"GTM-M6KWFCN","googleMapKey":"AIzaSyCMwAn-iWkMRePdSQ9ZTFv5Uzdech0iVBY","favicon":{"url":"https://media.permira.com/media/bqjph5wp/permira_favicon-01.png","alt":"permira favicon"},"header":{"searchLabel":"Search","logoWhiteImage":{"url":"https://media.permira.com/media/opchnm2m/logo-light.png","alt":"permira logo white 2"},"logoBlueImage":{"url":"https://media.permira.com/media/teup2dbc/logo-dark.png","alt":"permira logo blue 2"},"logoLink":"/","navigation":[{"text":"People","colourOption":null,"link":{"target":"","url":"/people/"},"image":{"url":"https://media.permira.com/media/d4jjudku/ea-option-1.jpg","alt":""},"description":"A global team bound by a distinct culture. Our collaborative and entrepreneurial culture unites a diverse team of 480+ individuals across 15 offices around the world.  ","cta":{"text":"MEET OUR PEOPLE","link":{"target":"","url":"/people/meet-our-people/"}},"leftPadding":false,"children":[{"text":"Meet Our People","colourOption":"","link":{"target":"","url":"/people/meet-our-people/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Culture and Values","colourOption":"","link":{"target":"","url":"/people/culture-and-values/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Life at Permira","colourOption":"","link":{"target":"","url":"/people/life-at-permira/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"Investing","colourOption":null,"link":{"target":"","url":"/investing/"},"image":{"url":"https://media.permira.com/media/bkhlrm3m/bosco-shots-slr66yjpsoi-unsplash-2.jpg","alt":""},"description":"We apply a thematic approach across two core asset classes - Private Equity and Credit - with a focus on growth in our four key sectors of expertise: Technology, Consumer, Healthcare and Services. ","cta":{"text":"LEARN MORE","link":{"target":"","url":"/investing/"}},"leftPadding":false,"children":[{"text":"Buyout","colourOption":"","link":{"target":"","url":"/investing/buyout/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Growth Equity","colourOption":"","link":{"target":"","url":"/investing/growth-equity/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Credit","colourOption":"","link":{"target":"","url":"/investing/credit/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"Portfolio","colourOption":null,"link":{"target":"","url":"/portfolio/"},"image":{"url":"https://media.permira.com/media/x3ibcksn/shutterstock_691685071-1.jpg","alt":""},"description":"We're supporting management teams and entrepreneurs, helping them to drive growth at scale and long-term value creation across four core sectors.  ","cta":{"text":"READ MORE","link":{"target":"","url":"/portfolio/"}},"leftPadding":false,"children":[{"text":"Our Portfolio","colourOption":"Orange","link":{"target":"","url":"/portfolio/our-portfolio/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Technology","colourOption":"","link":{"target":"","url":"/portfolio/technology/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Consumer","colourOption":"","link":{"target":"","url":"/portfolio/consumer/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Healthcare","colourOption":"","link":{"target":"","url":"/portfolio/healthcare/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Services","colourOption":"","link":{"target":"","url":"/portfolio/services/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"Value Creation Team","colourOption":"","link":{"target":"","url":"/portfolio/value-creation-team/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]}]},{"text":"Responsibility","colourOption":null,"link":{"target":"","url":"/responsibility/"},"image":{"url":"https://media.permira.com/media/nb5i4akv/joel-filipe-asl4k-u3i_s-unsplash.jpeg","alt":""},"description":"A values-based approach and a deep commitment to ESG guide our thinking. ","cta":{"text":"LEARN ABOUT OUR APPROACH","link":{"target":"","url":"/responsibility/"}},"leftPadding":false,"children":[{"text":"Investing Responsibly ","colourOption":"","link":{"target":"","url":"/responsibility/investing-responsibly/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"The Permira Foundation","colourOption":"","link":{"target":"","url":"/responsibility/permira-foundation/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"News \u0026 Insights","colourOption":null,"link":{"target":"","url":"/news-and-insights/"},"image":{"url":"https://media.permira.com/media/mgrhse35/rectangle-20387.jpg","alt":"Management meeting - Private equity services - Permira"},"description":"Explore articles, press releases, views and opinions from Permira, across our portfolio and the industry.","cta":{"text":"","link":{"target":"","url":""}},"leftPadding":false,"children":[{"text":"Insights","colourOption":"","link":{"target":"","url":"/news-and-insights/insights/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"News","colourOption":"","link":{"target":"","url":"/news-and-insights/news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"In the News","colourOption":"","link":{"target":"","url":"/news-and-insights/in-the-news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"About","colourOption":null,"link":{"target":"","url":"/about/"},"image":{"url":"https://media.permira.com/media/hikfrq4b/shutterstock_1880519176.jpg","alt":""},"description":"Driving long-term value creation. Accelerating sustainable growth at scale. Partnering to unlock potential.","cta":{"text":"READ MORE","link":{"target":"","url":"/about/permira-today/"}},"leftPadding":false,"children":[{"text":"Permira Today","colourOption":"","link":{"target":"","url":"/about/permira-today/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]}],"secondNavigation":[{"text":"Contact Us","colourOption":null,"link":{"target":"","url":"/contact-us/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"International Sites","colourOption":null,"link":{"target":"","url":""},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[{"text":"Permira China","colourOption":null,"link":{"target":"_blank","url":"https://www.permira.cn/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]}]},"search":{"link":{"target":"","url":"/search"}},"footer":{"logoImage":{"url":"https://media.permira.com/media/duglf2pa/logowhite.png","alt":"permira logo white"},"logoLink":"/","navigation":[[{"text":"People","items":[{"text":"Meet Our People","colourOption":null,"link":{"target":"","url":"/people/meet-our-people/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Culture and Values","colourOption":null,"link":{"target":"","url":"/people/culture-and-values/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Life at Permira","colourOption":null,"link":{"target":"","url":"/people/life-at-permira/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/people/"}},{"text":"Responsibility","items":[{"text":"Investing Responsibly","colourOption":null,"link":{"target":"","url":"/responsibility/investing-responsibly/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"The Permira Foundation","colourOption":null,"link":{"target":"","url":"/responsibility/permira-foundation/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/responsibility/"}}],[{"text":"Investing","items":[{"text":"Buyout","colourOption":null,"link":{"target":"","url":"/investing/buyout/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Growth Equity","colourOption":null,"link":{"target":"","url":"/investing/growth-equity/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Credit","colourOption":null,"link":{"target":"","url":"/investing/credit/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/investing/"}},{"text":"Insights \u0026 News","items":[{"text":"Insights","colourOption":null,"link":{"target":"","url":"/news-and-insights/insights/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"News","colourOption":null,"link":{"target":"","url":"/news-and-insights/news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/about/"}}],[{"text":"Portfolio","items":[{"text":"Our Portfolio","colourOption":null,"link":{"target":"","url":"/portfolio/our-portfolio/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Technology","colourOption":null,"link":{"target":"","url":"/portfolio/technology/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Consumer","colourOption":null,"link":{"target":"","url":"/portfolio/consumer/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Healthcare","colourOption":null,"link":{"target":"","url":"/portfolio/healthcare/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Services","colourOption":null,"link":{"target":"","url":"/portfolio/services/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/portfolio/"}},{"text":"About","items":[{"text":"Permira Today","colourOption":null,"link":{"target":"","url":"/about/permira-today/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/about/"}}],[{"text":"Others","items":[{"text":"Governance","colourOption":null,"link":{"target":"","url":"/governance/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Legal","colourOption":null,"link":{"target":"","url":"/legal/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Privacy Policy","colourOption":null,"link":{"target":"","url":"/privacy-policy/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Cookie Notice","colourOption":null,"link":{"target":"","url":"/cookie-notice/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"MSA","colourOption":null,"link":{"target":"","url":"/modern-slavery-act/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"PGL","colourOption":null,"link":{"target":"","url":"/pgl/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Pillar 3 Disclosures","colourOption":null,"link":{"target":"","url":"/pillar-3-disclosures/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"CRD IV Disclosure","colourOption":null,"link":{"target":"","url":"/crd-iv-disclosure/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"MIFIDPRU 8 Disclosures","colourOption":null,"link":{"target":"","url":"/mifidpru-8-disclosures/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":""}}]],"subscription":{"placeholder":"EMAIL ADDRESS","buttonLabel":"SUBMIT"}},"footerGroup":{"title":"Connect with us","copyrightText":"© 2024 Permira I.P Limited","socialMedia":[{"icon":"wechat","link":{"target":"","url":"https://media.permira.com/media/3ivl4au1/wechat-qr.jpg"}},{"icon":"vimeo","link":{"target":"_blank","url":"https://vimeo.com/permiraadvisers#"}},{"icon":"youtube","link":{"target":"","url":"https://www.youtube.com/user/PermiraTV#"}},{"icon":"twitter","link":{"target":"","url":"https://twitter.com/PermiraNews#"}},{"icon":"linkedin","link":{"target":"","url":"https://www.linkedin.com/company/permira#"}}]},"cookies":{"description":"\u003cp\u003eThis website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Please click on the link \"\u003ca rel=\"noopener noreferrer\" href=\"/cookie-notice\" target=\"_blank\" title=\"Cookie Notice\"\u003eLearn More\u003c/a\u003e\" if you would like more information about the cookies used on this website and how to change your cookies settings. Otherwise, we will assume you're OK to continue.\u003c/p\u003e","acceptBtn":"Accept Cookies","rejectBtn":"Reject Cookies"}},"Seo":{"pageTitle":"Neuraxpharm | Permira","pageDescription":"Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.","pageUrl":"https://www.permira.com/portfolio/our-portfolio/neuraxpharm/","pageKeywords":"","pageOgTitle":"Neuraxpharm | Permira","pageOgDescription":"Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.","pageOgImage":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","pageSeoStructuredData":"{\"@context\" : \"http://schema.org\",\n \"@type\" : \"Organization\",  \n  \"name\" : \"Permira\",\n  \"url\" : \"https://www.permira.com\", \n  \"logo\": \"https://media.permira.com/media/4d3gjitw/og-image_permira_logo.png\" \n}"},"Contents":[{"items":[{"text":"Home","path":"/"},{"text":"Portfolio","path":"/portfolio/"},{"text":"Our Portfolio","path":"/portfolio/our-portfolio/"},{"text":"Neuraxpharm","path":"/portfolio/our-portfolio/neuraxpharm/"}],"display":true,"type":"breadcrumb","isInner":true,"popup":true},{"type":"portfolioBasicInfo","title":"Neuraxpharm","description":"\u003cI\u003e “We are very excited to join forces with Neuraxpharm. The team has built one of the most relevant European players in the CNS field.” \u003c/I\u003e\u003cbr /\u003e\u003cb\u003e Dr. Jörg Rockenhäuser - Partner and Head of DACH at Permira \u003c/b\u003e\u003cbr /\u003e\u003cbr /\u003eNeuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.\u003cbr /\u003e\u003cbr /\u003eWith one of the broadest and most diversified product portfolios of over 130 CNS molecules, a strong medical reputation and deep CNS experience, the company holds leading positions in its core markets, Germany and Spain, and across Europe in many of its CNS molecules. \u003cbr /\u003e\u003cbr /\u003eThe Company also enjoys a strong track record of successfully in-licensing innovative CNS drugs and has emerged as a go-to commercialization \u0026 distribution partner in Europe. \u003cbr /\u003e","icon":{"url":"https://media.permira.com/media/lvwnaywl/neuraxpharm_logo.png","alt":""},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"stats":[{"title":"2020","description":"\u003cp\u003eInvestment year\u003c/p\u003e","disableCountingAnimation":false},{"title":"\u003e130","description":"\u003cp\u003eCNS Molecules\u003c/p\u003e","disableCountingAnimation":false},{"title":"#1","description":"\u003cp\u003eCNS specialist in Europe\u003c/p\u003e","disableCountingAnimation":false}],"download":{"title":null,"sector":null,"publishingDate":null,"cta":{"text":null,"link":null},"image":null,"mobileImage":null},"caseStudy":{"text":null,"link":null},"detail":{"title":"DETAILS","sector":{"title":"Sector","value":"Healthcare","countries":null},"countryRegion":{"title":"Country or Region","value":null,"countries":[{"text":"Germany","link":{"target":"","url":"/portfolio/our-portfolio/?countryRegion=germany"}},{"text":"Spain","link":{"target":"","url":"/portfolio/our-portfolio/?countryRegion=spain"}}]},"status":{"title":"Status","value":"Current","countries":null},"website":{"title":"Website","value":"www.neuraxpharm.com","countries":null}},"publishingDate":null,"quotes":null,"popup":true},{"type":"peopleList","title":"Related Team","disclaimerText":"","items":[{"id":"7d983a93-bbb2-42c6-8cfe-8b565237b192","name":"David Brueckmann","title":"Principal","link":{"target":"","url":"/people/meet-our-people/david-brueckmann/"},"image":{"url":"https://media.permira.com/media/zv1ltrzs/david-brueckmann.png","alt":""}},{"id":"b7411177-c3a3-4139-aab2-2906566b3304","name":"Javier Echávarri Fernández","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/javier-echavarri-fernandez/"},"image":{"url":"https://media.permira.com/media/ulrlmjd2/javier-echavarri.jpg","alt":""}},{"id":"750973e4-89b1-4a8c-a935-7e5e7ac6cc8a","name":"Ulrich Gasse","title":"Senior Adviser","link":{"target":"","url":"/people/meet-our-people/ulrich-gasse/"},"image":{"url":"https://media.permira.com/media/51rdgy2z/ulrich-gasse.jpg","alt":""}},{"id":"fb5a7d0e-99ee-4d93-9b9e-29179527b3ce","name":"Florian Kreuzer","title":"Principal, Head of DACH","link":{"target":"","url":"/people/meet-our-people/florian-kreuzer/"},"image":{"url":"https://media.permira.com/media/r4xna4hu/florian-kreuzer.jpg","alt":""}},{"id":"f8151dab-7d2a-4086-ac81-5e618ca379fe","name":"Pedro López","title":"Partner, Head of Spain","link":{"target":"","url":"/people/meet-our-people/pedro-lopez/"},"image":{"url":"https://media.permira.com/media/tgjh4sfj/pedro-lopez.jpg","alt":""}},{"id":"3ce0cec5-4d71-4a1a-ae2c-b6463ba8779e","name":"Timon Müller-Gastell","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/timon-muller-gastell/"},"image":{"url":"https://media.permira.com/media/ybpojvgf/timon-muller-gastell_web.jpg","alt":""}},{"id":"4c6748f5-3176-45c5-a0c2-e1fb4ed2a335","name":"Silvia Oteri","title":"Partner, Head of Healthcare","link":{"target":"","url":"/people/meet-our-people/silvia-oteri/"},"image":{"url":"https://media.permira.com/media/pxclxrvd/silvia-oteri.jpg","alt":""}},{"id":"d33dd624-e00b-440f-a562-2857ea11eaae","name":"José Maria Palicio","title":"Principal","link":{"target":"","url":"/people/meet-our-people/jose-maria-palicio/"},"image":{"url":"https://media.permira.com/media/xe3cb4oh/josemaria-palicio.png","alt":""}},{"id":"d8d851e9-f478-4e31-839e-48d2498dec9e","name":"Jörg Rockenhäuser","title":"Partner, Chairman DACH","link":{"target":"","url":"/people/meet-our-people/jorg-rockenhauser/"},"image":{"url":"https://media.permira.com/media/3tcb0qxn/jorg-rockenhauser.jpg","alt":""}},{"id":"6c4a6ed4-5606-4d2d-9f36-a75d8ed4dd63","name":"Simon Roggentin","title":"Principal","link":{"target":"","url":"/people/meet-our-people/simon-roggentin/"},"image":{"url":"https://media.permira.com/media/rrlncns5/simon-roggentin-permira.png","alt":""}},{"id":"af6d6620-f002-4f4a-8b11-7812a277bec6","name":"Michael Reichard","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/michael-reichard/"},"image":{"url":"https://media.permira.com/media/1jyl5m0m/michael-reichard_web.jpg","alt":""}},{"id":"84b594ba-6132-4e82-8507-da54e3c48d23","name":"Felix Wallner","title":"Associate","link":{"target":"","url":"/people/meet-our-people/felix-wallner/"},"image":{"url":"https://media.permira.com/media/3kkhicpg/felix-wallner_web.jpg","alt":""}}],"cta":{"text":"","link":{"target":"","url":""}},"popup":true},{"type":"relatedNewsViewsBox","title":"Related News \u0026 Insights","items":[{"id":"6dfcf18c-2407-4e4b-98e2-2ec3f41e8419","title":"TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy) ","author":{"id":"a7efd745-78b5-4973-9169-e3c98beabbdc","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/lxudi4pn/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/tg-therapeutics-and-neuraxpharm-announce-ex-us-commercialization-agreement-for-briumvi-ublituximab-xiiy/"},"publishingDate":"1 Aug 2023","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/tg-therapeutics-and-neuraxpharm-announce-ex-us-commercialization-agreement-for-briumvi-ublituximab-xiiy/"}}},{"id":"1e5052e7-d20e-4be9-9e8c-60c22842e72d","title":"Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg","author":{"id":"4eda85b0-819a-4b71-a607-44598802bbee","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg/"},"publishingDate":"24 Jan 2023","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg/"}}},{"id":"8866d606-f1b8-4925-a90e-86d54025835f","title":"Neuraxpharm expands into the Netherlands","author":{"id":"7dc3ff24-f63c-4496-a0bf-6aa0637b791e","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-into-the-netherlands/"},"publishingDate":"13 Dec 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-into-the-netherlands/"}}},{"id":"2c439f42-861c-4089-9132-eb1ab9c12565","title":"Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures","author":{"id":"2d95d72a-1881-48d8-93ac-5cb467af65eb","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-steps-into-the-digital-health-market-with-a-wearable-device-developed-by-mjn-neuro-that-provides-an-early-warning-of-epileptic-seizures/"},"publishingDate":"25 Oct 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-steps-into-the-digital-health-market-with-a-wearable-device-developed-by-mjn-neuro-that-provides-an-early-warning-of-epileptic-seizures/"}}},{"id":"cf73c6b5-2b89-4aa1-b30c-e254037c988f","title":"Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi","author":{"id":"a569453a-cff7-411e-83ec-6365f96f9a71","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi/"},"publishingDate":"12 Jul 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi/"}}},{"id":"ad53a6ea-8225-4b76-93df-92988135fb46","title":"Neuraxpharm expands its business in Southeast Europe","author":{"id":"e7dec50e-d5d4-4b11-8633-f0195d4fa2ae","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-its-business-in-southeast-europe/"},"publishingDate":"8 Mar 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-its-business-in-southeast-europe/"}}},{"id":"0e6cebb7-9c76-45d4-a24a-2a3ba78855cc","title":"Neuraxpharm appoints commercial expert Dr. Maximilian von Wülfing as Chief Operating Officer","author":{"id":"ce0e15de-26e8-4f93-be25-c8aa8ffbec80","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-appoints-commercial-expert-dr-maximilian-von-wulfing-as-chief-operating-officer/"},"publishingDate":"1 Jun 2021","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-appoints-commercial-expert-dr-maximilian-von-wulfing-as-chief-operating-officer/"}}},{"id":"74dac16d-8116-4acd-8b52-a6a5dc94a21d","title":"Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix","author":{"id":"5ce92013-8253-4667-abbb-834eefca98b0","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix/"},"publishingDate":"14 Dec 2020","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix/"}}},{"id":"e77ae6ee-fb0f-4232-a29d-cfcdfe1afc1b","title":"Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm","author":{"id":"3c1cf602-6cc8-4382-9a30-906b2b5a4e7b","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/permira-funds-to-acquire-leading-european-cns-specialty-pharmaceutical-company-neuraxpharm/"},"publishingDate":"22 Sep 2020","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/permira-funds-to-acquire-leading-european-cns-specialty-pharmaceutical-company-neuraxpharm/"}}}],"cta":{"text":"","link":{"target":"","url":""}},"popup":true},{"type":"esgReportList","title":"Reporting","description":"","items":[{"title":"Neuraxpharm ESG Report 2022","sector":"Healthcare","publishingDate":"12 Oct 2023","cta":{"text":"Download","link":{"target":"","url":"https://media.permira.com/media/03oflejj/neuraxpharm-esg-report-2022.pdf"}},"image":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""},"mobileImage":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""}}],"cta":{"text":"","link":{"target":"","url":""}},"popup":true}],"breadcrumb":{"items":[{"text":"Home","path":"/"},{"text":"Portfolio","path":"/portfolio/"},{"text":"Our Portfolio","path":"/portfolio/our-portfolio/"},{"text":"Neuraxpharm","path":"/portfolio/our-portfolio/neuraxpharm/"}],"display":true},"isErrorPage":false,"_sentryTraceData":"acd42085f3ea49ebac9333df4c5079f9-8006a6e5cc8bf108-0","_sentryBaggage":"sentry-environment=production,sentry-release=6ZnPWxhlX7ngAr_ybXEs9,sentry-public_key=a6cd43701caa45079dcab344c6c857f2,sentry-trace_id=acd42085f3ea49ebac9333df4c5079f9,sentry-sample_rate=0,sentry-transaction=%2Fportfolio%2Four-portfolio%2F%5B...pagepath%5D,sentry-sampled=false"}},"initialState":{"page":{"page":{"id":"4a13d9c5-e952-4a47-8908-4891af693585","name":"Neuraxpharm","SEO":{"pageTitle":"Neuraxpharm | Permira","pageDescription":"Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.","pageUrl":"https://www.permira.com/portfolio/our-portfolio/neuraxpharm/","pageKeywords":"","pageOgTitle":"Neuraxpharm | Permira","pageOgDescription":"Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.","pageOgImage":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","pageSeoStructuredData":"{\"@context\" : \"http://schema.org\",\n \"@type\" : \"Organization\",  \n  \"name\" : \"Permira\",\n  \"url\" : \"https://www.permira.com\", \n  \"logo\": \"https://media.permira.com/media/4d3gjitw/og-image_permira_logo.png\" \n}"},"breadcrumb":{"items":[{"text":"Home","path":"/"},{"text":"Portfolio","path":"/portfolio/"},{"text":"Our Portfolio","path":"/portfolio/our-portfolio/"},{"text":"Neuraxpharm","path":"/portfolio/our-portfolio/neuraxpharm/"}],"display":true},"contents":[{"type":"portfolioBasicInfo","title":"Neuraxpharm","description":"\u003cI\u003e “We are very excited to join forces with Neuraxpharm. The team has built one of the most relevant European players in the CNS field.” \u003c/I\u003e\u003cbr /\u003e\u003cb\u003e Dr. Jörg Rockenhäuser - Partner and Head of DACH at Permira \u003c/b\u003e\u003cbr /\u003e\u003cbr /\u003eNeuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of the central nervous system (“CNS”). Neuraxpharm develops and commercialises value-added medicines for patients suffering from chronic neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, Multiple Sclerosis, depression, and psychosis.\u003cbr /\u003e\u003cbr /\u003eWith one of the broadest and most diversified product portfolios of over 130 CNS molecules, a strong medical reputation and deep CNS experience, the company holds leading positions in its core markets, Germany and Spain, and across Europe in many of its CNS molecules. \u003cbr /\u003e\u003cbr /\u003eThe Company also enjoys a strong track record of successfully in-licensing innovative CNS drugs and has emerged as a go-to commercialization \u0026 distribution partner in Europe. \u003cbr /\u003e","icon":{"url":"https://media.permira.com/media/lvwnaywl/neuraxpharm_logo.png","alt":""},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"stats":[{"title":"2020","description":"\u003cp\u003eInvestment year\u003c/p\u003e","disableCountingAnimation":false},{"title":"\u003e130","description":"\u003cp\u003eCNS Molecules\u003c/p\u003e","disableCountingAnimation":false},{"title":"#1","description":"\u003cp\u003eCNS specialist in Europe\u003c/p\u003e","disableCountingAnimation":false}],"download":{"title":null,"sector":null,"publishingDate":null,"cta":{"text":null,"link":null},"image":null,"mobileImage":null},"caseStudy":{"text":null,"link":null},"detail":{"title":"DETAILS","sector":{"title":"Sector","value":"Healthcare","countries":null},"countryRegion":{"title":"Country or Region","value":null,"countries":[{"text":"Germany","link":{"target":"","url":"/portfolio/our-portfolio/?countryRegion=germany"}},{"text":"Spain","link":{"target":"","url":"/portfolio/our-portfolio/?countryRegion=spain"}}]},"status":{"title":"Status","value":"Current","countries":null},"website":{"title":"Website","value":"www.neuraxpharm.com","countries":null}},"publishingDate":null},{"type":"peopleList","title":"Related Team","disclaimerText":"","items":[{"id":"7d983a93-bbb2-42c6-8cfe-8b565237b192","name":"David Brueckmann","title":"Principal","link":{"target":"","url":"/people/meet-our-people/david-brueckmann/"},"image":{"url":"https://media.permira.com/media/zv1ltrzs/david-brueckmann.png","alt":""}},{"id":"b7411177-c3a3-4139-aab2-2906566b3304","name":"Javier Echávarri Fernández","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/javier-echavarri-fernandez/"},"image":{"url":"https://media.permira.com/media/ulrlmjd2/javier-echavarri.jpg","alt":""}},{"id":"750973e4-89b1-4a8c-a935-7e5e7ac6cc8a","name":"Ulrich Gasse","title":"Senior Adviser","link":{"target":"","url":"/people/meet-our-people/ulrich-gasse/"},"image":{"url":"https://media.permira.com/media/51rdgy2z/ulrich-gasse.jpg","alt":""}},{"id":"fb5a7d0e-99ee-4d93-9b9e-29179527b3ce","name":"Florian Kreuzer","title":"Principal, Head of DACH","link":{"target":"","url":"/people/meet-our-people/florian-kreuzer/"},"image":{"url":"https://media.permira.com/media/r4xna4hu/florian-kreuzer.jpg","alt":""}},{"id":"f8151dab-7d2a-4086-ac81-5e618ca379fe","name":"Pedro López","title":"Partner, Head of Spain","link":{"target":"","url":"/people/meet-our-people/pedro-lopez/"},"image":{"url":"https://media.permira.com/media/tgjh4sfj/pedro-lopez.jpg","alt":""}},{"id":"3ce0cec5-4d71-4a1a-ae2c-b6463ba8779e","name":"Timon Müller-Gastell","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/timon-muller-gastell/"},"image":{"url":"https://media.permira.com/media/ybpojvgf/timon-muller-gastell_web.jpg","alt":""}},{"id":"4c6748f5-3176-45c5-a0c2-e1fb4ed2a335","name":"Silvia Oteri","title":"Partner, Head of Healthcare","link":{"target":"","url":"/people/meet-our-people/silvia-oteri/"},"image":{"url":"https://media.permira.com/media/pxclxrvd/silvia-oteri.jpg","alt":""}},{"id":"d33dd624-e00b-440f-a562-2857ea11eaae","name":"José Maria Palicio","title":"Principal","link":{"target":"","url":"/people/meet-our-people/jose-maria-palicio/"},"image":{"url":"https://media.permira.com/media/xe3cb4oh/josemaria-palicio.png","alt":""}},{"id":"d8d851e9-f478-4e31-839e-48d2498dec9e","name":"Jörg Rockenhäuser","title":"Partner, Chairman DACH","link":{"target":"","url":"/people/meet-our-people/jorg-rockenhauser/"},"image":{"url":"https://media.permira.com/media/3tcb0qxn/jorg-rockenhauser.jpg","alt":""}},{"id":"6c4a6ed4-5606-4d2d-9f36-a75d8ed4dd63","name":"Simon Roggentin","title":"Principal","link":{"target":"","url":"/people/meet-our-people/simon-roggentin/"},"image":{"url":"https://media.permira.com/media/rrlncns5/simon-roggentin-permira.png","alt":""}},{"id":"af6d6620-f002-4f4a-8b11-7812a277bec6","name":"Michael Reichard","title":"Vice President","link":{"target":"","url":"/people/meet-our-people/michael-reichard/"},"image":{"url":"https://media.permira.com/media/1jyl5m0m/michael-reichard_web.jpg","alt":""}},{"id":"84b594ba-6132-4e82-8507-da54e3c48d23","name":"Felix Wallner","title":"Associate","link":{"target":"","url":"/people/meet-our-people/felix-wallner/"},"image":{"url":"https://media.permira.com/media/3kkhicpg/felix-wallner_web.jpg","alt":""}}],"cta":{"text":"","link":{"target":"","url":""}}},{"type":"relatedNewsViewsBox","title":"Related News \u0026 Insights","items":[{"id":"6dfcf18c-2407-4e4b-98e2-2ec3f41e8419","title":"TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy) ","author":{"id":"a7efd745-78b5-4973-9169-e3c98beabbdc","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/lxudi4pn/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/tg-therapeutics-and-neuraxpharm-announce-ex-us-commercialization-agreement-for-briumvi-ublituximab-xiiy/"},"publishingDate":"1 Aug 2023","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/tg-therapeutics-and-neuraxpharm-announce-ex-us-commercialization-agreement-for-briumvi-ublituximab-xiiy/"}}},{"id":"1e5052e7-d20e-4be9-9e8c-60c22842e72d","title":"Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg","author":{"id":"4eda85b0-819a-4b71-a607-44598802bbee","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg/"},"publishingDate":"24 Jan 2023","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-completes-its-presence-in-benelux-by-opening-an-affiliate-in-brussels-to-cover-belgium-and-luxembourg/"}}},{"id":"8866d606-f1b8-4925-a90e-86d54025835f","title":"Neuraxpharm expands into the Netherlands","author":{"id":"7dc3ff24-f63c-4496-a0bf-6aa0637b791e","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-into-the-netherlands/"},"publishingDate":"13 Dec 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-into-the-netherlands/"}}},{"id":"2c439f42-861c-4089-9132-eb1ab9c12565","title":"Neuraxpharm steps into the Digital Health market with a wearable device developed by mjn-neuro that provides an early warning of epileptic seizures","author":{"id":"2d95d72a-1881-48d8-93ac-5cb467af65eb","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/ov3o5ytm/neuraxpharm-featured-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-steps-into-the-digital-health-market-with-a-wearable-device-developed-by-mjn-neuro-that-provides-an-early-warning-of-epileptic-seizures/"},"publishingDate":"25 Oct 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-steps-into-the-digital-health-market-with-a-wearable-device-developed-by-mjn-neuro-that-provides-an-early-warning-of-epileptic-seizures/"}}},{"id":"cf73c6b5-2b89-4aa1-b30c-e254037c988f","title":"Neuraxpharm to increase branded business through upcoming acquisition of established products from Sanofi","author":{"id":"a569453a-cff7-411e-83ec-6365f96f9a71","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi/"},"publishingDate":"12 Jul 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-to-increase-branded-business-through-upcoming-acquisition-of-established-products-from-sanofi/"}}},{"id":"ad53a6ea-8225-4b76-93df-92988135fb46","title":"Neuraxpharm expands its business in Southeast Europe","author":{"id":"e7dec50e-d5d4-4b11-8633-f0195d4fa2ae","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-its-business-in-southeast-europe/"},"publishingDate":"8 Mar 2022","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-expands-its-business-in-southeast-europe/"}}},{"id":"0e6cebb7-9c76-45d4-a24a-2a3ba78855cc","title":"Neuraxpharm appoints commercial expert Dr. Maximilian von Wülfing as Chief Operating Officer","author":{"id":"ce0e15de-26e8-4f93-be25-c8aa8ffbec80","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-appoints-commercial-expert-dr-maximilian-von-wulfing-as-chief-operating-officer/"},"publishingDate":"1 Jun 2021","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-appoints-commercial-expert-dr-maximilian-von-wulfing-as-chief-operating-officer/"}}},{"id":"74dac16d-8116-4acd-8b52-a6a5dc94a21d","title":"Neuraxpharm establishes operations in the Republic of Ireland through the acquisition of Medinutrix","author":{"id":"5ce92013-8253-4667-abbb-834eefca98b0","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix/"},"publishingDate":"14 Dec 2020","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/neuraxpharm-establishes-operations-in-the-republic-of-ireland-through-the-acquisition-of-medinutrix/"}}},{"id":"e77ae6ee-fb0f-4232-a29d-cfcdfe1afc1b","title":"Permira funds to acquire leading European CNS specialty pharmaceutical company Neuraxpharm","author":{"id":"3c1cf602-6cc8-4382-9a30-906b2b5a4e7b","name":"","image":{"url":"","alt":""}},"image":{"url":"https://media.permira.com/media/rcankzzi/neuraxpharm-building.jpg","alt":"Neuraxpharm logo on a building"},"link":{"target":"","url":"/news-and-insights/news/permira-funds-to-acquire-leading-european-cns-specialty-pharmaceutical-company-neuraxpharm/"},"publishingDate":"22 Sep 2020","type":"News","articleType":"article","tags":[],"cta":{"text":"READ MORE","link":{"target":"","url":"/news-and-insights/news/permira-funds-to-acquire-leading-european-cns-specialty-pharmaceutical-company-neuraxpharm/"}}}],"cta":{"text":"","link":{"target":"","url":""}}},{"type":"esgReportList","title":"Reporting","description":"","items":[{"title":"Neuraxpharm ESG Report 2022","sector":"Healthcare","publishingDate":"12 Oct 2023","cta":{"text":"Download","link":{"target":"","url":"https://media.permira.com/media/03oflejj/neuraxpharm-esg-report-2022.pdf"}},"image":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""},"mobileImage":{"url":"https://media.permira.com/media/nnzc3bg2/generic-news-image.jpg","alt":""}}],"cta":{"text":"","link":{"target":"","url":""}}}]},"pageInit":true,"pageLoading":false},"global":{"globalData":{"data":{"id":"1192c9f6-9299-4d0b-83c4-39d01d01c618","ga_id":"GTM-M6KWFCN","googleMapKey":"AIzaSyCMwAn-iWkMRePdSQ9ZTFv5Uzdech0iVBY","favicon":{"url":"https://media.permira.com/media/bqjph5wp/permira_favicon-01.png","alt":"permira favicon"},"header":{"searchLabel":"Search","logoWhiteImage":{"url":"https://media.permira.com/media/opchnm2m/logo-light.png","alt":"permira logo white 2"},"logoBlueImage":{"url":"https://media.permira.com/media/teup2dbc/logo-dark.png","alt":"permira logo blue 2"},"logoLink":"/","navigation":[{"text":"People","colourOption":null,"link":{"target":"","url":"/people/"},"image":{"url":"https://media.permira.com/media/d4jjudku/ea-option-1.jpg","alt":""},"description":"A global team bound by a distinct culture. Our collaborative and entrepreneurial culture unites a diverse team of 480+ individuals across 15 offices around the world.  ","cta":{"text":"MEET OUR PEOPLE","link":{"target":"","url":"/people/meet-our-people/"}},"leftPadding":false,"children":[{"text":"Meet Our People","colourOption":"","link":{"target":"","url":"/people/meet-our-people/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Culture and Values","colourOption":"","link":{"target":"","url":"/people/culture-and-values/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Life at Permira","colourOption":"","link":{"target":"","url":"/people/life-at-permira/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"Investing","colourOption":null,"link":{"target":"","url":"/investing/"},"image":{"url":"https://media.permira.com/media/bkhlrm3m/bosco-shots-slr66yjpsoi-unsplash-2.jpg","alt":""},"description":"We apply a thematic approach across two core asset classes - Private Equity and Credit - with a focus on growth in our four key sectors of expertise: Technology, Consumer, Healthcare and Services. ","cta":{"text":"LEARN MORE","link":{"target":"","url":"/investing/"}},"leftPadding":false,"children":[{"text":"Buyout","colourOption":"","link":{"target":"","url":"/investing/buyout/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Growth Equity","colourOption":"","link":{"target":"","url":"/investing/growth-equity/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Credit","colourOption":"","link":{"target":"","url":"/investing/credit/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"Portfolio","colourOption":null,"link":{"target":"","url":"/portfolio/"},"image":{"url":"https://media.permira.com/media/x3ibcksn/shutterstock_691685071-1.jpg","alt":""},"description":"We're supporting management teams and entrepreneurs, helping them to drive growth at scale and long-term value creation across four core sectors.  ","cta":{"text":"READ MORE","link":{"target":"","url":"/portfolio/"}},"leftPadding":false,"children":[{"text":"Our Portfolio","colourOption":"Orange","link":{"target":"","url":"/portfolio/our-portfolio/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Technology","colourOption":"","link":{"target":"","url":"/portfolio/technology/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Consumer","colourOption":"","link":{"target":"","url":"/portfolio/consumer/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Healthcare","colourOption":"","link":{"target":"","url":"/portfolio/healthcare/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"   Services","colourOption":"","link":{"target":"","url":"/portfolio/services/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]},{"text":"Value Creation Team","colourOption":"","link":{"target":"","url":"/portfolio/value-creation-team/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":true,"children":[]}]},{"text":"Responsibility","colourOption":null,"link":{"target":"","url":"/responsibility/"},"image":{"url":"https://media.permira.com/media/nb5i4akv/joel-filipe-asl4k-u3i_s-unsplash.jpeg","alt":""},"description":"A values-based approach and a deep commitment to ESG guide our thinking. ","cta":{"text":"LEARN ABOUT OUR APPROACH","link":{"target":"","url":"/responsibility/"}},"leftPadding":false,"children":[{"text":"Investing Responsibly ","colourOption":"","link":{"target":"","url":"/responsibility/investing-responsibly/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"The Permira Foundation","colourOption":"","link":{"target":"","url":"/responsibility/permira-foundation/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"News \u0026 Insights","colourOption":null,"link":{"target":"","url":"/news-and-insights/"},"image":{"url":"https://media.permira.com/media/mgrhse35/rectangle-20387.jpg","alt":"Management meeting - Private equity services - Permira"},"description":"Explore articles, press releases, views and opinions from Permira, across our portfolio and the industry.","cta":{"text":"","link":{"target":"","url":""}},"leftPadding":false,"children":[{"text":"Insights","colourOption":"","link":{"target":"","url":"/news-and-insights/insights/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"News","colourOption":"","link":{"target":"","url":"/news-and-insights/news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"In the News","colourOption":"","link":{"target":"","url":"/news-and-insights/in-the-news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]},{"text":"About","colourOption":null,"link":{"target":"","url":"/about/"},"image":{"url":"https://media.permira.com/media/hikfrq4b/shutterstock_1880519176.jpg","alt":""},"description":"Driving long-term value creation. Accelerating sustainable growth at scale. Partnering to unlock potential.","cta":{"text":"READ MORE","link":{"target":"","url":"/about/permira-today/"}},"leftPadding":false,"children":[{"text":"Permira Today","colourOption":"","link":{"target":"","url":"/about/permira-today/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]}],"secondNavigation":[{"text":"Contact Us","colourOption":null,"link":{"target":"","url":"/contact-us/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"International Sites","colourOption":null,"link":{"target":"","url":""},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[{"text":"Permira China","colourOption":null,"link":{"target":"_blank","url":"https://www.permira.cn/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}]}]},"search":{"link":{"target":"","url":"/search"}},"footer":{"logoImage":{"url":"https://media.permira.com/media/duglf2pa/logowhite.png","alt":"permira logo white"},"logoLink":"/","navigation":[[{"text":"People","items":[{"text":"Meet Our People","colourOption":null,"link":{"target":"","url":"/people/meet-our-people/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Culture and Values","colourOption":null,"link":{"target":"","url":"/people/culture-and-values/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Life at Permira","colourOption":null,"link":{"target":"","url":"/people/life-at-permira/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/people/"}},{"text":"Responsibility","items":[{"text":"Investing Responsibly","colourOption":null,"link":{"target":"","url":"/responsibility/investing-responsibly/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"The Permira Foundation","colourOption":null,"link":{"target":"","url":"/responsibility/permira-foundation/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/responsibility/"}}],[{"text":"Investing","items":[{"text":"Buyout","colourOption":null,"link":{"target":"","url":"/investing/buyout/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Growth Equity","colourOption":null,"link":{"target":"","url":"/investing/growth-equity/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Credit","colourOption":null,"link":{"target":"","url":"/investing/credit/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/investing/"}},{"text":"Insights \u0026 News","items":[{"text":"Insights","colourOption":null,"link":{"target":"","url":"/news-and-insights/insights/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"News","colourOption":null,"link":{"target":"","url":"/news-and-insights/news/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/about/"}}],[{"text":"Portfolio","items":[{"text":"Our Portfolio","colourOption":null,"link":{"target":"","url":"/portfolio/our-portfolio/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Technology","colourOption":null,"link":{"target":"","url":"/portfolio/technology/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Consumer","colourOption":null,"link":{"target":"","url":"/portfolio/consumer/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Healthcare","colourOption":null,"link":{"target":"","url":"/portfolio/healthcare/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Services","colourOption":null,"link":{"target":"","url":"/portfolio/services/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/portfolio/"}},{"text":"About","items":[{"text":"Permira Today","colourOption":null,"link":{"target":"","url":"/about/permira-today/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":"/about/"}}],[{"text":"Others","items":[{"text":"Governance","colourOption":null,"link":{"target":"","url":"/governance/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Legal","colourOption":null,"link":{"target":"","url":"/legal/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Privacy Policy","colourOption":null,"link":{"target":"","url":"/privacy-policy/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Cookie Notice","colourOption":null,"link":{"target":"","url":"/cookie-notice/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"MSA","colourOption":null,"link":{"target":"","url":"/modern-slavery-act/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"PGL","colourOption":null,"link":{"target":"","url":"/pgl/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"Pillar 3 Disclosures","colourOption":null,"link":{"target":"","url":"/pillar-3-disclosures/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"CRD IV Disclosure","colourOption":null,"link":{"target":"","url":"/crd-iv-disclosure/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]},{"text":"MIFIDPRU 8 Disclosures","colourOption":null,"link":{"target":"","url":"/mifidpru-8-disclosures/"},"image":{"url":"","alt":""},"description":"","cta":{"text":"","link":{"target":"","url":null}},"leftPadding":false,"children":[]}],"link":{"target":"","url":""}}]],"subscription":{"placeholder":"EMAIL ADDRESS","buttonLabel":"SUBMIT"}},"footerGroup":{"title":"Connect with us","copyrightText":"© 2024 Permira I.P Limited","socialMedia":[{"icon":"wechat","link":{"target":"","url":"https://media.permira.com/media/3ivl4au1/wechat-qr.jpg"}},{"icon":"vimeo","link":{"target":"_blank","url":"https://vimeo.com/permiraadvisers#"}},{"icon":"youtube","link":{"target":"","url":"https://www.youtube.com/user/PermiraTV#"}},{"icon":"twitter","link":{"target":"","url":"https://twitter.com/PermiraNews#"}},{"icon":"linkedin","link":{"target":"","url":"https://www.linkedin.com/company/permira#"}}]},"cookies":{"description":"\u003cp\u003eThis website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Please click on the link \"\u003ca rel=\"noopener noreferrer\" href=\"/cookie-notice\" target=\"_blank\" title=\"Cookie Notice\"\u003eLearn More\u003c/a\u003e\" if you would like more information about the cookies used on this website and how to change your cookies settings. Otherwise, we will assume you're OK to continue.\u003c/p\u003e","acceptBtn":"Accept Cookies","rejectBtn":"Reject Cookies"}}},"globalInit":true,"globalLoading":false,"globalLang":{},"cookieAccept":false},"people":{"filters":[],"peoples":{},"peoplesInit":false,"peoplesLoading":false},"portfolio":{"filters":[],"portfolio":{},"portfolioInit":false,"portfolioLoading":false},"news":{"filters":[],"news":{},"newsInit":false,"newsLoading":false},"search":{"result":{},"success":false,"loading":false},"playerModal":{"open":false,"link":""},"pageModal":{"page":{},"pageInit":false,"pageLoading":false},"caseStudy":{"filters":[],"caseStudy":{},"caseStudyInit":false,"caseStudyLoading":false},"reports":{"filters":[],"reports":{},"reportsInit":false,"reportsLoading":false}},"pageProps":{"_sentryTraceData":"acd42085f3ea49ebac9333df4c5079f9-8006a6e5cc8bf108-0","_sentryBaggage":"sentry-environment=production,sentry-release=6ZnPWxhlX7ngAr_ybXEs9,sentry-public_key=a6cd43701caa45079dcab344c6c857f2,sentry-trace_id=acd42085f3ea49ebac9333df4c5079f9,sentry-sample_rate=0,sentry-transaction=%2Fportfolio%2Four-portfolio%2F%5B...pagepath%5D,sentry-sampled=false"}},"page":"/portfolio/our-portfolio/[...pagepath]","query":{"pagepath":["neuraxpharm"]},"buildId":"6ZnPWxhlX7ngAr_ybXEs9","isFallback":false,"gip":true,"appGip":true,"scriptLoader":[]}</script></body></html>